Original document(26 pages) Authorized document(26 pages) 中文版
    The characteristic is to insert a designed synthetic human gammar type interferon (IFN-gamma) group into colibacillus carrier containing gammar bacteriophage PL primary gene to build IFN-gamma expression particles, the IFN-gamma produced by the engineering bacteria containing the said particles reaches 60-80% of the total amount of bacteria soluble protein, the produced IFN-gamma are concentrated in the inclusion body, so that after separating the inclusion body, the purity of IFN-gamma reaches 90%, then through one step molecular sieve column chromatography, the purity can reach above 96%, the specific activity is 2X10 to the power 7 IU/mg.protein.
Application Number
申请号
94112091 Application Date
申请日
1994.03.29
Title 名称 high demonstration by artificial human gama-insterferon gene (c DNA) in colonbacillus
Publication Number
公开号
1109506 Publication Date
公开日
1995.10.04
Approval Pub. Date Granted Pub. Date 2001.01.17
International Classification 分类号 C12N15/23,C12N15/73
Applicant(s) Name
申请人
Shanghai Biochemical Inst., Chinese Academy of Sciences
Address 地址 200031
Inventor(s) Name 发明人
Attorney & Agent 代理人 ZHONG CHENGXUAN WANG KEZHEN

  
Synthesis of gene, constitution of expression plasmid and processing technology of product for human leucocytolysin-2
Protein and polypeptide mercapto-polyglycol (PEG) reagent
Constitution of gene synthesized expressive plasmid for human Inter leukin-2 gene and producing process of its products
Regulatory sequence of alpha-fetoprotein gene expression and its application
Interleukin -2/granulocyte-macrophage colony stimulating factor fusion protein
High-efficiency expression of artificially synthetic interferon alpha-2b gene in colibacillus
Method for testing application of interleukin-2 gene in chronic pain
Preparation of target gene virus medicine against cancers
Tumour targeting bigene-virus structure method
Tumor target gene-virus ZD55-IL-24, construction method and application thereof
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.